We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$705M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Royal Bank of Canada
RY
$291B
| $129M | 0.14% |
2,189,773
-20,780
| -0.9% | -$1.25M |
|
152
PUT
Invesco QQQ Trust
QQQ
$453B
| $127M | 0.14% |
1,183,069
-291,200
| -20% | -$31.5M |
|
153
Mondelez International
MDLZ
$79.5B
| $127M | 0.13% |
2,780,293
-1,271,256
| -31% | -$55.4M |
|
154
Danaher
DHR
$137B
| $126M | 0.13% |
2,455,128
-20,046
| -0.8% | -$1.31M |
|
155
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $126M | 0.13% |
6,281,448
+1,505,643
| +32% | +$30.5M |
|
156
Amphenol
APH
$198B
| $125M | 0.13% |
8,717,448
-1,896,804
| -18% | -$27.3M |
|
|
AGN
157
PUT
DELISTED
Allergan plc
AGN
| $125M | 0.13% |
540,600
+290,500
| +116% | +$67M |
|
158
Labcorp
LH
$25B
| $125M | 0.13% |
1,114,105
+111,040
| +11% | +$11.9M |
|
159
PUT
Visa
V
$684B
| $124M | 0.13% |
1,676,700
+656,200
| +64% | +$51.4M |
|
160
PUT
Gilead Sciences
GILD
$162B
| $124M | 0.13% |
1,489,300
+640,000
| +75% | +$56.8M |
|
161
PUT
Pfizer
PFE
$143B
| $123M | 0.13% |
3,691,319
+1,758,705
| +91% | +$56.1M |
|
162
Ingredion
INGR
$6.27B
| $123M | 0.13% |
952,084
-157,079
| -14% | -$18.3M |
|
163
Ametek
AME
$55.4B
| $122M | 0.13% |
2,643,103
-398,966
| -13% | -$19.2M |
|
164
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $121M | 0.13% |
1,253,683
-195,146
| -13% | -$18.6M |
|
165
Northrop Grumman
NOC
$77.1B
| $121M | 0.13% |
542,523
-60,489
| -10% | -$12.7M |
|
166
Lockheed Martin
LMT
$134B
| $120M | 0.13% |
484,676
-125,856
| -21% | -$29.7M |
|
167
Phillips 66
PSX
$84.9B
| $120M | 0.13% |
1,506,180
+95,457
| +7% | +$7.8M |
|
|
BRCD
168
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $119M | 0.13% |
12,933,100
-1,377,286
| -10% | -$12.3M |
|
169
TJX Companies
TJX
$174B
| $118M | 0.13% |
3,050,714
-835,816
| -22% | -$31.9M |
|
170
PUT
UnitedHealth
UNH
$376B
| $117M | 0.12% |
827,100
+307,600
| +59% | +$41M |
|
171
Applied Materials
AMAT
$403B
| $117M | 0.12% |
4,863,232
+1,290,989
| +36% | +$28.5M |
|
172
Cardinal Health
CAH
$53.9B
| $116M | 0.12% |
1,489,404
+29,430
| +2% | +$2.35M |
|
173
PUT
Boeing
BA
$171B
| $115M | 0.12% |
885,400
+515,600
| +139% | +$67.2M |
|
174
Johnson Controls International
JCI
$88.8B
| $114M | 0.12% |
2,452,394
+35,839
| +1% | +$1.58M |
|
175
Hewlett Packard
HPE
$63.4B
| $111M | 0.12% |
10,481,726
+2,814,804
| +37% | +$28.6M |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.